| Dr Maryann Gushue, MD | |
|
21 Geisinger Ln, Lewistown, PA 17044-3400 | |
| (717) 242-4200 | |
| (717) 242-4212 |
| Full Name | Dr Maryann Gushue |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 21 Geisinger Ln, Lewistown, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740259597 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD023372E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maryann Gushue, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144 | Dr Maryann Gushue, MD 21 Geisinger Ln, Lewistown, PA 17044-3400 Ph: (717) 242-4200 |
News Archive
Female mice deprived of dietary zinc for a relatively short time before conception experienced fertility and pregnancy problems and had smaller, less-developed fetuses than mice that ingested zinc during the same times, according to researchers in Penn State's College of Agricultural Sciences.
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.
Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.
Inhibitex, Inc., announced today that it has recently commenced dosing in a 90-patient randomized, placebo controlled, treatment guided, Phase 2 clinical trial to evaluate the safety, tolerability and antiviral activity of INX-189 in combination with pegylated interferon and ribavirin in chronic HCV-infected genotype 2 and 3 treatment naïve patients.
› Verified 2 days ago
Colt Brackbill, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Geisinger Ln, Lewistown, PA 17044 Phone: 717-242-4200 Fax: 717-242-4212 | |
Dr. Scott Kenneth Andrews, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Geisinger Ln, Lewistown, PA 17044 Phone: 717-242-4200 Fax: 717-242-4212 | |
Nicki Vithalani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Third St, Lewistown, PA 17044 Phone: 717-242-7297 Fax: 717-242-7741 | |
David Eugene Schooley, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 70 Dr Schooley Ln, Lewistown, PA 17044 Phone: 717-248-5147 | |
Dr. Cybele Pacheco, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Geisinger Ln, Lewistown, PA 17044 Phone: 717-242-4200 | |
Dr. Raymond F. Nungesser, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 21 Geisinger Ln, Lewistown, PA 17044 Phone: 717-242-4200 Fax: 717-242-4212 | |
Karanvir Singh, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 21 Geisinger Ln, Lewistown, PA 17044 Phone: 717-242-4200 |